Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Will today be our 1st 10 million share day?

Good point, Brian and if you take into account, the OTCBB practices for reporting volume traded per day, then the volume is 1/2 of what is reported. OTCBB volume reporting follows that of the Nazdaq whereby both buys and sells are counted as shares traded. One must divide by at least a factor of 2 to get an accurate account of the % of actual shares traded.

http://www.lehigh.edu/~incbeug/Attachments/Anderson%20Trading%20Volume%20paper.pdf

Share
New Message
Please login to post a reply